ArticleCardiovascular diabetology2023

Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors.

Lucia Scisciola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.